Matches in Wikidata for { <http://www.wikidata.org/entity/Q66083341> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q66083341 description "clinical trial" @default.
- Q66083341 description "ensayu clínicu" @default.
- Q66083341 description "klinisch onderzoek" @default.
- Q66083341 description "клінічне випробування" @default.
- Q66083341 name "Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder" @default.
- Q66083341 name "Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder" @default.
- Q66083341 type Item @default.
- Q66083341 label "Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder" @default.
- Q66083341 label "Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder" @default.
- Q66083341 prefLabel "Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder" @default.
- Q66083341 prefLabel "Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder" @default.
- Q66083341 P1050 Q66083341-96D9D93A-EFEA-4C9F-A86D-012F75C07D75 @default.
- Q66083341 P1132 Q66083341-6F66EEE2-12C4-45D4-ADAB-B470C77515FB @default.
- Q66083341 P1476 Q66083341-BD456B63-1968-47CC-B42C-6F21EC57FBC6 @default.
- Q66083341 P2899 Q66083341-A134EC33-9C05-48A6-B316-D4ECB64107F9 @default.
- Q66083341 P3098 Q66083341-362B70E3-092F-4229-9541-40E6CAD6F027 @default.
- Q66083341 P31 Q66083341-2B1403C2-8AC4-4B45-AB76-ADFD3F15A12D @default.
- Q66083341 P580 Q66083341-DEEA0F75-5D00-446B-B5FD-DCED8103C7F0 @default.
- Q66083341 P582 Q66083341-19B72124-04EB-4E9F-A938-F81E6BCFF095 @default.
- Q66083341 P6099 Q66083341-9E747413-3B26-424F-83E3-84D8D2EC3F54 @default.
- Q66083341 P8363 Q66083341-6EDEEFD2-DA34-4683-85D7-11669E737991 @default.
- Q66083341 P1050 Q611458 @default.
- Q66083341 P1132 "+5" @default.
- Q66083341 P1476 "Single-center, Open Label Trial of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder" @default.
- Q66083341 P2899 "+18" @default.
- Q66083341 P3098 "NCT02893111" @default.
- Q66083341 P31 Q30612 @default.
- Q66083341 P580 "2015-12-01T00:00:00Z" @default.
- Q66083341 P582 "2016-12-25T00:00:00Z" @default.
- Q66083341 P6099 Q42824440 @default.
- Q66083341 P8363 Q78089383 @default.